LGNDLIGAND PHARMACEUTICALS INCvs its industry peers
A metric-by-metric comparison of LIGAND PHARMACEUTICALS INC against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LGND본 종목 | $6.0B#7 | 120.1x#2 | 6.2x#4 | 22.3x#4 | 60.4%#2 | 3186.6%#1 | 15.3%#1 | 12.9%#2 | 1.6%#2 | — | — | — |
| PRAX | $7.3B#1 | — | 5.5x#2 | — | -100.0%#7 | -65.6%#8 | — | -22.6%#6 | — | — | — | — |
| RYTM | $7.3B#2 | — | 82.9x#8 | 38.4x#5 | 45.8%#3 | 24.6%#4 | -101.2%#5 | -0.2%#3 | -127.5%#4 | — | — | — |
| AXSM | $6.8B#3 | — | 64.7x#7 | 10.7x#3 | 65.5%#1 | 36.2%#3 | -26.1%#3 | -173.7%#9 | — | — | — | — |
| IONS | $6.4B#4 | — | 14.7x#6 | 6.8x#2 | 33.8%#4 | 16.0%#6 | -40.4%#4 | -86.7%#8 | -20.6%#3 | — | — | — |
| ORKA | $6.4B#5 | — | 5.7x#3 | — | — | -25.9%#7 | — | -9.5%#4 | — | — | — | — |
| AMRX | $6.2B#6 | 40.5x#1 | 188.1x#9 | 2.1x#1 | 8.0%#5 | 161.6%#2 | 13.1%#2 | 218.2%#1 | 14.6%#1 | 6#1 | — | — |
| DNTH | $4.7B#8 | — | 3.8x#1 | 2301.2x#6 | -67.3%#6 | -91.1%#9 | -8739.3%#6 | -13.1%#5 | — | — | — | — |
| ERAS | $4.6B#9 | — | 12.7x#5 | — | — | 23.0%#5 | — | -34.4%#7 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-06.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice